News: How drugs could repair damage from... (NIH Research Matters) - Behind the headlines
In the news
Media coverage of health and science topics
How drugs could repair damage from multiple sclerosis
Drugs that help repair the nerve cell lining that’s damaged in multiple sclerosis were found to target certain enzymes. The finding could help researchers develop new treatments for multiple sclerosis.
Read more at NIH Research Matters
Behind the headlines
Research findings and data from the National Library of Medicine
PubMed articles
Accumulation of 8,9-unsaturated sterols drives oligodendrocyte formation and remyelination
Regeneration of myelin is mediated by oligodendrocyte progenitor cells-an abundant stem cell population in the central nervous system (CNS) and the principal source of ne …
Induction of myelinating oligodendrocytes in human cortical spheroids
Cerebral organoids provide an accessible system for investigations of cellular composition, interactions, and organization but have lacked oligodendrocytes, the myelinati …
Related content
Similar articles
Reviews
People also viewed
Also of interest
Additional recent and related news
A Brain-Eating Amoeba Just Claimed Another Victim
Naegleria fowleri lays waste to cells in the brain, leading to a grisly demise in the very rare cases when it manages to lodge itself in a victim's nasal cavity.
A cellular map of brain lesions in multiple sclerosis
Researchers created a detailed map of cells in the expanding lesions involved in more disabling forms of multiple sclerosis.
What is multiple sclerosis? - CNN
Multiple sclerosis is a disease that affects the central nervous system and is considered an autoimmune disease, in which the immune system attacks its own healthy cells. It affects quality of life and can be disabling.
Study suggests Epstein-Barr virus may cause multiple sclerosis
Infection with Epstein-Barr virus, scientists found, dramatically increased the odds of developing multiple sclerosis.
Patients Still Struggle To Balance High Costs Of MS Treatment, Despite Generic
Drugs to treat multiple sclerosis can run $70,000 a year or more. Patients hoped competition from a generic version of one of the most popular brands would spur relief, but prices went up. Here's why.